Thursday, March 3, 2022

< + > WHO Backs Merck’s Antiviral Pill For High-Risk Covid Patients But Finds Regeneron’s Antibody Cocktail ‘Ineffective’ Against Omicron

The WHO panel is also evaluating data for Pfizer’s antiviral pill, paxlovid, and a widely available antidepressant, fluvoxamine, to treat Covid-19.

No comments:

Post a Comment

< + > Stop Waiting on Mandates: CMS Challenges Health IT to Act Now

“We’re the government and we’re here to help.” That’s a common punchline, but based on recent IT announcements from CMS, this line may turn ...